Dr. Reisfeld is an Assistant Professor in the Department of Chemical and Biological Engineering and Department of Environmental and Radiological Health Sciences at Colorado State University. He received his Ph.D. in Chemical Engineer from Northwestern University and was a postdoctoral fellow at the Johns Hopkins School of Medicine in the Department of Biomedical Engineering.
His research interests lie in areas of biological and biomedical science that are directly relevant to human health and are interdisciplinary in nature. His focus, at present, is in examining the fate of xenobiotics in the body. This includes examining the issues of biodistribution, clearance, and especially metabolism as they relate to the formation and elimination of reactive metabolites involved in carcinogenesis and other adverse health effects. His current projects include developing a computer-assisted approach for the analysis and prediction of xenobiotic metabolism, developing a methodology for predicting the feasibility of cytochrome P450 isozyme binding of xenobiotics, using physiologically-based pharmacokinetic modeling to predict the biodistribution of probe compounds in the body, and using NMR imaging to investigate the very early stages of chemically-induced carcinogenesis.